
CRDN supports Health Canada with insights and recommendations for genetic rare disease diagnostics
CRDN provided Health Canada with national insights and recommendations to advance early and equitable rare disease diagnosis.
News related to rare disease, including patient stories, new programs and initiatives, and more.

CRDN provided Health Canada with national insights and recommendations to advance early and equitable rare disease diagnosis.

On May 26, the 78th World Health Assembly (WHA78) voted unanimously for the resolution “Rare diseases: a global health priority for equity and inclusion,” the first time the World Health Organization has formally elevated rare diseases to the top tier of its agenda.

The Canadian Rare Disease Innovation Showcase brought together powerful stories and cutting-edge science—from AI diagnostics to patient-led research—to inspire bold action across Canada’s rare disease community

CRDN joined leaders from across Canada at the RareKids-CAN Conference and co-hosted a mini workshop on pre-clinical therapy development.

On Rare Disease Day 2025, CRDN participated in national events, fostering collaboration, raising awareness, and sharing updates on progress thus far..

The RDI-Lancet Commission on Rare Diseases has officially launched, co-chaired by CRDN’s own Dr. Kym Boycott, to develop evidence-based policy solutions that enhance healthcare for Persons Living with a Rare Disease (PLWRD) worldwide.
Stay updated with the latest developments and events from the CRDN as we advance rare disease research and care across Canada.

Dr. François Bernier and Dr. Catherine Strandt attended the 2026 ERDERA General Assembly in Portugal to learn about ongoing initiatives and explore opportunities to advance international rare disease research collaboration.

CRDN celebrates continued federal funding for Canada’s rare disease drug strategy and highlights the importance of connecting treatment access with timely diagnosis, coordinated care, and research.

Natasha Trehan, a 2026 RAREvolution Scholar, reflects on life beyond diagnosis and treatment as CRDN builds opportunities for peer connection, mentorship, and engagement through its inaugural scholarship program.

Five parent caregivers from across Canada have completed a year-long research training program, bringing their lived experience to a study exploring strength, support, and well-being among families affected by rare diseases.

CRDN’s third Open Access Government article explores why Canada must invest in the people, expertise, and clinical systems needed to turn genomic advances into timely and equitable rare disease diagnosis.

CRDN was pleased to attend the 2026 NMD4C Annual Meeting in Calgary, bringing together members of the neuromuscular disease community for a full day of research updates, strategic discussions, collaboration, and connection.